Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lakewood-Amedex Biotherapeutics Inc. (LABT) — insider trading: 0 buys, 0 sells · InsiderLens

Home / Companies / Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics Inc.

LABT

Insider trading at Lakewood-Amedex Biotherapeutics Inc.

Transactions on record: 1; since May 6, 2026

Insider buys: 0

Insider sells: 0

Active insiders · 12 months: 1; last filing May 6, 2026

Figures computed from official regulatory filings — methodology.

Current insiders at Lakewood-Amedex Biotherapeutics Inc.

Balzer ThomasChief Medical Officer
Ceccacci PeterChief Financial Officer
Cooper KelvinDirector
Cooper KelvinChief Executive Officer
DeRoma Leonard JamesDirector
Tucker Joseph EdwardDirector

Insider transaction history at Lakewood-Amedex Biotherapeutics Inc.

Insider	Filed	Type	Qty	Price	Value · USD	Src
Tucker Joseph Edward	May 6, 2026	AwardD	33,784	0.00 USD	$0	SEC